Logo for HUTCHMED (China) Limited

HUTCHMED (China) Investor Relations Material

Latest events

Logo for HUTCHMED (China) Limited

H1 2023

HUTCHMED (China)
Logo for HUTCHMED (China)

H1 2023

31 Jul, 2023
Logo for HUTCHMED (China)

H2 2022

28 Feb, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
HUTCHMED (China) Limited was founded to discover, develop, and commercialize targeted therapeutics and immunotherapies for cancer and immunological diseases. The company have developed a core platform technology which combines three unique developments from both the laboratory and their experience with pharmaceutical artificial intelligence: data-driven design of next-generation antibodies, prediction of off-target binding sites, and targeted delivery of therapeutic agents.